10月9日，苏博特盘中上涨2.02%，截至10:01，报10.63元/股，成交2387.66万元，换手率0.54%，总市值 45.32亿元。 分红方面，苏博特A股上市后累计派现7.40亿元。近三年，累计派现2.34亿元。 资金流向方面，主力资金净流出39.02万元，大单买入139.97万元，占比5.86%，卖出178.99万元，占比 7.50%。 苏博特今年以来股价涨44.43%，近5个交易日跌0.28%，近20日跌1.30%，近60日涨14.92%。 今年以来苏博特已经3次登上龙虎榜，最近一次登上龙虎榜为7月25日，当日龙虎榜净买入-5396.97万 元；买入总计6065.22万元 ，占总成交额比5.81%；卖出总计1.15亿元 ，占总成交额比10.97%。 资料显示，江苏苏博特新材料股份有限公司位于江苏省南京市江宁区淳化街道醴泉路118号，成立日期 2004年12月15日，上市日期2017年11月10日，公司主营业务涉及混凝土外加剂的研发、生产和销售。主 营业务收入构成为：高性能减水剂51.83%，功能性材料20.74%，技术服务20.21%，其他5.53%，高效减 水剂1.15%，其他(补充)0.55% ...

Group 1 - The core viewpoint of the news is that Wanrun Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.11% to 13.79 CNY per share, and a total market capitalization of 12.728 billion CNY [1] - Wanrun Co., Ltd. is engaged in three main business areas: electronic information materials, environmental protection materials, and health industry products, with functional materials accounting for 78.58% of revenue, life sciences and pharmaceuticals for 20.09%, and other categories for 1.33% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Wanrun Co., Ltd., specifically the Galaxy New Materials Stock Initiation A (020276), which reduced its holdings by 5,800 shares in the second quarter, maintaining 53,700 shares, representing 5.26% of the fund's net value [2] - The Galaxy New Materials Stock Initiation A (020276) has achieved a year-to-date return of 32.29%, ranking 1479 out of 4220 in its category, and a one-year return of 62.93%, ranking 1436 out of 3814 [2] - The fund manager of Galaxy New Materials Stock Initiation A is Jin Ye, who has been in the position for approximately 3 years and 265 days, with the fund's total asset size at 54.3398 million CNY [3]

Company Summary - Shihua Technology (SH 688093) announced the completion of the issuance of approximately 17.75 million new shares on September 19, 2025, with a subscription price of 33.8 yuan per share, raising a total of approximately 600 million yuan [1] - The newly issued shares are subject to a six-month lock-up period, during which they cannot be transferred [1] - As of the report date, Shihua Technology has a market capitalization of 11.1 billion yuan [1] Revenue Composition - For the year 2024, Shihua Technology's revenue composition is as follows: functional materials account for 99.79% and other businesses account for 0.21% [1]

Group 1 - The company, Shihua Technology, announced that its third board meeting will be held on September 19, 2025, to review the adjustment of fundraising project amounts [1] - For the year 2024, the company's revenue composition is 99.79% from functional materials and 0.21% from other businesses [1] - As of the report, Shihua Technology has a market capitalization of 11.1 billion yuan [1]

Group 1 - The Shenzhen Stock Exchange will hold its 20th listing review meeting on September 19, 2025, to review the application of Suzhou New Guangyi Electronics Co., Ltd. [1] - New Guangyi plans to raise funds amounting to 638.383 million yuan for its functional materials project [2][3] - The total investment for the functional materials project is 638.383 million yuan, which matches the amount of funds to be raised [3]

Company Overview - Su Bote New Materials Co., Ltd. is located in Nanjing, Jiangsu Province, established on December 15, 2004, and listed on November 10, 2017. The company specializes in the research, production, and sales of concrete additives [1][2]. Financial Performance - For the first half of 2025, Su Bote achieved operating revenue of 1.673 billion yuan, representing a year-on-year growth of 7.03%. The net profit attributable to shareholders was 63.245 million yuan, an increase of 18.68% year-on-year [2]. - Since its A-share listing, Su Bote has distributed a total of 740 million yuan in dividends, with 234 million yuan distributed over the past three years [3]. Stock Performance - As of September 10, Su Bote's stock price increased by 2.01%, reaching 11.15 yuan per share, with a total market capitalization of 4.753 billion yuan. The stock has risen by 51.49% year-to-date [1]. - The stock has seen a trading volume of 54.66 million yuan with a turnover rate of 1.19%. The net outflow of main funds was 1.1986 million yuan, with large orders accounting for 5.00% of total buy and 7.19% of total sell [1]. Shareholder Information - As of June 30, 2025, the number of shareholders increased to 19,300, with an average of 21,807 circulating shares per person, a decrease of 1.53% from the previous period [2]. - Among the top ten circulating shareholders, Noan Pioneer Mixed A (320003) is the sixth largest, holding 5.6563 million shares as a new shareholder [3]. Business Segments - The main business revenue composition includes high-performance water-reducing agents (51.83%), functional materials (20.74%), technical services (20.21%), and others [1].

Investment Rating - The report maintains an "Outperform" rating for the company [2] Core Views - The company's revenue and profit recovery is increasingly certain, with a year-on-year revenue growth of 7.0% in the first half of 2025 and a net profit increase of 18.7% [7] - The company has a strong technical and research capability, supported by national-level laboratories and recognized engineering teams, which enhances its competitive edge in major infrastructure projects [7] - The company is expected to achieve net profits of 223 million, 287 million, and 344 million yuan for the years 2025, 2026, and 2027 respectively, corresponding to PE valuations of 21, 16, and 13 times [7] Financial Data and Profit Forecast - Total revenue is projected to be 3,911 million yuan in 2025, with a year-on-year growth rate of 10.0% [6] - The company’s net profit for 2025 is estimated at 223 million yuan, reflecting a significant recovery from a previous decline [6] - The gross profit margin is expected to be 31.7% in 2025, with a return on equity (ROE) of 5.1% [6] Company Performance - In the second quarter of 2025, the company achieved a revenue of 9.9 billion yuan, with a year-on-year growth of 0.7% and a net profit of 0.39 billion yuan, up 20.9% year-on-year [7] - The company’s main products showed a trend of increasing volume but decreasing prices, particularly in functional materials, which have become a significant growth driver [7]

Group 1: Market Dynamics - 26 new private placement projects were added in the last two weeks, a 8.33% increase from the previous period, with 17 being competitive bids[5] - The number of projects terminated remained stable at 10, with 6 being competitive bids[5] - The approval rate for projects was 100%, with 5 projects approved by the review committee, a decrease of 50% from the previous period[5] Group 2: Fundraising and Pricing - A total of 166.42 billion CNY was raised from 9 projects, a staggering 1613.24% increase compared to the previous period[34] - The average base discount rate for competitive projects was 12.59%, up 6.78 percentage points, while the market price discount rate averaged 13.27%, down 0.86 percentage points[34] - The average market price discount rate for non-competitive projects was 33.37%[34] Group 3: Competitive Bidding Insights - The average number of institutions participating in competitive bids was 25, with an average allocation rate of 63.86%, an increase of 28.44 percentage points[43] - The average premium rate for competitive bids was 8.52%, down 3.44 percentage points from the previous period[43] Group 4: Project Analysis - Aikodi plans to raise up to 520 million CNY for acquisitions, with a projected PE of 10.25X, lower than its current PE of 20.18X[25] - Lukan Pharmaceutical aims to raise up to 1.2 billion CNY for high-end formulation projects, with a market outlook driven by aging population and chronic diseases[27]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown significant improvement in its performance, with a revenue of 1.673 billion yuan in H1 2025, representing a year-on-year growth of 7.03%, and a net profit attributable to the parent company of 63 million yuan, up 18.68% year-on-year [6] - The company is expected to benefit from the recovery in downstream demand, particularly as a leading producer of water-reducing agents, with forecasts for net profits of 153 million, 204 million, and 244 million yuan for 2025, 2026, and 2027 respectively [6] - The company has expanded its product offerings and increased its market competitiveness, particularly in the functional materials segment, which saw a revenue growth of over 25% year-on-year in Q2 2025 [6][7] Financial Summary - In Q2 2025, the company achieved a revenue of 999 million yuan, a year-on-year increase of 0.70% and a quarter-on-quarter increase of 45.45%, with a net profit of 39 million yuan, up 20.86% year-on-year and 59.97% quarter-on-quarter [6] - The company's high-performance water-reducing agents and functional materials segments showed strong sales growth, with respective sales volumes of 306,000 tons and 107,900 tons in Q2 2025 [6] - The financial projections indicate a steady increase in revenue and net profit over the next few years, with expected revenues of 3.839 billion, 4.247 billion, and 4.963 billion yuan for 2025, 2026, and 2027 respectively [8] Market Expansion - The company is actively expanding its presence in the domestic infrastructure market, particularly in major projects in the western regions, and has achieved notable results in sectors such as hydropower, nuclear power, and railways [7] - The company has also established new subsidiaries in overseas markets including the Philippines, Singapore, and Thailand, enhancing its international business footprint [7]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook on its stock performance [6]. Core Views - The company has shown a continuous improvement in profit margins, with functional materials maintaining high growth rates. The revenue for the first half of 2025 reached 1.67 billion yuan, a year-on-year increase of 7.0%, and the net profit attributable to shareholders was 63 million yuan, up 18.7% year-on-year [1][4]. - The company is a leader in the water-reducing agent industry, with strong technical capabilities and high customer recognition. It is involved in numerous key engineering projects, which supports its revenue growth [4]. Summary by Sections Financial Performance - In Q2 2025, the company achieved revenue of 990 million yuan, a slight increase of 0.7% year-on-year, and a net profit of 390 million yuan, up 20.9% year-on-year [1]. - The gross margin for the first half of 2025 was 34.7%, a slight decline of 0.1 percentage points year-on-year, while the net profit margin was 5.9%, down 0.5 percentage points year-on-year [3]. - The company’s revenue from high-performance water-reducing agents was 870 million yuan in the first half of 2025, a year-on-year increase of 6.3%, with a gross margin of 30.1% [2]. Revenue Breakdown - Functional materials generated revenue of 350 million yuan in the first half of 2025, reflecting a robust growth of 25.2% year-on-year, with a gross margin of 33.8% [2]. - Technical services revenue decreased by 7.6% year-on-year to 340 million yuan, with a gross margin of 53.9% [2]. Future Projections - The company is expected to achieve revenues of 3.8 billion yuan, 4.26 billion yuan, and 4.67 billion yuan for the years 2025, 2026, and 2027, respectively, with a projected net profit of 159 million yuan, 204 million yuan, and 245 million yuan for the same years [4][5]. - The anticipated growth rate for net profit over the next three years is 24.1%, with corresponding P/E ratios of 30X, 23X, and 19X [4].